NCT03120637View on ClinicalTrials.gov

Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 10, 2018

Study Completion Date

January 10, 2018

Conditions
Septic ShockVasoplegiaCirrhosis, LiverRefractory Shock
Interventions
DRUG

Methylene Blue

Trial Locations (1)

110070

Liver Coma ICU, Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT03120637 - Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue | Biotech Hunter | Biotech Hunter